Marvin Donald's Form 4 filing
Chemomab Therapeutics Ltd. (CMMB) · filed Jun 21, 2022
- Accession no.
- 0001178913-22-002402
- Filed
- Jun 21, 2022
- Trade date
- Nov 8, 2021-Mar 16, 2022
- Filing delay
- 225 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market purchases total $1.64K. It was filed 225 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Marvin DonaldCIK 0001891264 | Officer (Executive VP, CFO & COO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 16, 2022 | American Depositary Shares | PPurchaseAcquired | +250 | $3.30 | +$825 | 1,750 | Direct | |
| Mar 16, 2022 | American Depositary Shares | PPurchaseAcquired | +250 | $3.25 | +$812.5 | 2,000 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 8, 2021 | American Depositary Shares | AGrant or awardAcquired | +196,875 | $0.00 | $0 | 196,875 | Direct | Duplicate filing |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.